332 related articles for article (PubMed ID: 35082127)
41. Eosinophil ETosis-Mediated Release of Galectin-10 in Eosinophilic Granulomatosis With Polyangiitis.
Fukuchi M; Kamide Y; Ueki S; Miyabe Y; Konno Y; Oka N; Takeuchi H; Koyota S; Hirokawa M; Yamada T; Melo RCN; Weller PF; Taniguchi M
Arthritis Rheumatol; 2021 Sep; 73(9):1683-1693. PubMed ID: 33750029
[TBL] [Abstract][Full Text] [Related]
42. Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
Olaguibel JM; Sastre J; Rodríguez JM; Del Pozo V
J Investig Allergol Clin Immunol; 2022 Jun; 32(3):165-180. PubMed ID: 35522053
[TBL] [Abstract][Full Text] [Related]
43. [A Rare Cause of a Eosinophilic Lung Disease].
Stolpe C; Tannapfel A
Pneumologie; 2021 Mar; 75(3):221-225. PubMed ID: 32927489
[TBL] [Abstract][Full Text] [Related]
44. Experimental Modeling of Eosinophil-Associated Diseases.
Upparahalli Venkateshaiah S; Manohar M; Kandikattu HK; Mishra A
Methods Mol Biol; 2021; 2241():275-291. PubMed ID: 33486743
[TBL] [Abstract][Full Text] [Related]
45. Galectin-10 as a Potential Biomarker for Eosinophilic Diseases.
Tomizawa H; Yamada Y; Arima M; Miyabe Y; Fukuchi M; Hikichi H; Melo RCN; Yamada T; Ueki S
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291593
[TBL] [Abstract][Full Text] [Related]
46. An Atypical Case of Non-asthmatic Eosinophilic Granulomatosis with Polyangiitis Finally Diagnosed by Tissue Biopsy.
Kobayashi T; Kanno K; Kikuchi Y; Kakimoto M; Kawahara A; Kimura K; Ishida R; Miyamori D; Otani Y; Kishikawa N; Tazuma S
Intern Med; 2019 Mar; 58(6):871-875. PubMed ID: 30449779
[TBL] [Abstract][Full Text] [Related]
47. Eosinophils in Autoimmune Diseases.
Diny NL; Rose NR; Čiháková D
Front Immunol; 2017; 8():484. PubMed ID: 28496445
[TBL] [Abstract][Full Text] [Related]
48. Eosinophilic granulomatosis with polyangiitis: Cutaneous clinical and histopathologic differential diagnosis.
Tabb ES; Duncan LM; Nazarian RM
J Cutan Pathol; 2021 Nov; 48(11):1379-1386. PubMed ID: 34019312
[TBL] [Abstract][Full Text] [Related]
49. Exacerbation of Eosinophilic Granulomatosis With Polyangiitis After Administering Dupilumab for Severe Asthma and Eosinophilic Rhinosinusitis With Nasal Polyposis.
Tanaka S; Tsuji T; Shiotsu S; Yuba T; Hiraoka N
Cureus; 2022 May; 14(5):e25218. PubMed ID: 35747049
[TBL] [Abstract][Full Text] [Related]
50. Focus on the Involvement of the Nose and Paranasal Sinuses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Nasal Cytology Reveals Infiltration of Eosinophils as a Very Common Feature.
Seccia V; Baldini C; Latorre M; Gelardi M; Dallan I; Cristofani-Mencacci L; Sellari-Franceschini S; Bartoli ML; Bacci E; Paggiaro P
Int Arch Allergy Immunol; 2018; 175(1-2):61-69. PubMed ID: 29393242
[TBL] [Abstract][Full Text] [Related]
51. In vivo visualization of eosinophil secretion in eosinophilic granulomatosis with polyangiitis: An ultrastructural study.
Koike H; Nishi R; Furukawa S; Mouri N; Fukami Y; Iijima M; Katsuno M
Allergol Int; 2022 Jul; 71(3):373-382. PubMed ID: 35428588
[TBL] [Abstract][Full Text] [Related]
52. Primary eosinophilic lung diseases.
Rose DM; Hrncir DE
Allergy Asthma Proc; 2013; 34(1):19-25. PubMed ID: 23406932
[TBL] [Abstract][Full Text] [Related]
53. Eosinophils in vasculitis: characteristics and roles in pathogenesis.
Khoury P; Grayson PC; Klion AD
Nat Rev Rheumatol; 2014 Aug; 10(8):474-83. PubMed ID: 25003763
[TBL] [Abstract][Full Text] [Related]
54. Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia.
Zimmermann N; Wikenheiser-Brokamp KA
Ann Allergy Asthma Immunol; 2018 Aug; 121(2):179-185. PubMed ID: 29803709
[TBL] [Abstract][Full Text] [Related]
55. Eosinophils in Health and Disease: A State-of-the-Art Review.
Wechsler ME; Munitz A; Ackerman SJ; Drake MG; Jackson DJ; Wardlaw AJ; Dougan SK; Berdnikovs S; Schleich F; Matucci A; Chanez P; Prazma CM; Howarth P; Weller PF; Merkel PA
Mayo Clin Proc; 2021 Oct; 96(10):2694-2707. PubMed ID: 34538424
[TBL] [Abstract][Full Text] [Related]
56. Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma.
Roufosse F
Front Med (Lausanne); 2018; 5():49. PubMed ID: 29682504
[TBL] [Abstract][Full Text] [Related]
57. Hypereosinophilia with asthma and systemic (non-vasculitic) manifestations: Eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome?
Lefèvre G; Ackermann F; Kahn JE
Autoimmun Rev; 2017 Feb; 16(2):208-209. PubMed ID: 27915050
[No Abstract] [Full Text] [Related]
58. A case of eosinophilic granulomatosis with polyangiitis after prolonged intervals of an anti-interleukin-6 receptor antibody for rheumatoid arthritis.
Imai Y; Kondo Y; Ishigaki S; Nishina N; Ota Y; Hanaoka H; Kaneko Y; Takeuchi T
Mod Rheumatol Case Rep; 2022 Jan; 6(1):83-86. PubMed ID: 34477209
[TBL] [Abstract][Full Text] [Related]
59. Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma.
Hočevar A; Kopač P; Rotar Ž; Plešivčnik Novljan M; Škrgat S
Rheumatology (Oxford); 2021 Feb; 60(2):e78. PubMed ID: 33280004
[No Abstract] [Full Text] [Related]
60. Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis.
Padoan R; Chieco Bianchi F; Marchi MR; Cazzador D; Felicetti M; Emanuelli E; Vianello A; Nicolai P; Doria A; Schiavon F
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3225-3227.e2. PubMed ID: 32505716
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
